Piracetam for Treatment of Cocaine Addiction - 3

This study has been completed.

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) University of Pennsylvania
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000198

Purpose

The purpose of this study is to evaluate the effects of IV cocaine administration in cocaine dependent subjects maintained on piracetam while they are residing in an inpatient addictions treatment research unit and to subsequently follow these patients in an eight week open label assessment of piracetam in an outpatient treatment program.

Condition	Intervention	Phase
Cocaine-Related Disorders	Drug: Piracetam	Phase I

Drug Information available for: 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- Cocaine hydrochloride Piracetam

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment
Official Title:	Piracetam for Treatment of Cocaine Addiction

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Pulse, blood pressure
Adverse effects
High, anxiety, withdrawal

Estimated Enrollment:	0
Study Start Date:	October 1996

Eligibility

Ages Eligible for Study:	21 Years to 45 Years
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000198

Locations

United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104 6178

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Pennsylvania

Investigators

Principal Investigator:

Kyle Kampman, M.D.

University of Pennsylvania

More Information

Study ID Numbers:	NIDA-00238-3, K02-00238-3
Study First Received:	September 20, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00000198
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Cocaine-Related Disorders
Behavior, Addictive
Mental Disorders
Substance-Related Disorders

Piracetam
Disorders of Environmental Origin
Cocaine

Additional relevant MeSH terms:

Nootropic Agents
Therapeutic Uses
Physiological Effects of Drugs
Central Nervous System Agents

Protective Agents
Neuroprotective Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 15, 2009